164 related articles for article (PubMed ID: 38726104)
1. Applications of magnetic resonance spectroscopy in diagnosis of neurodegenerative diseases: A systematic review.
Abbaspour F; Mohammadi N; Amiri H; Cheraghi S; Ahadi R; Hormozi-Moghaddam Z
Heliyon; 2024 May; 10(9):e30521. PubMed ID: 38726104
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Spectroscopy (MRS) in Alzheimer's Disease.
Sheikh-Bahaei N; Chen M; Pappas I
Methods Mol Biol; 2024; 2785():115-142. PubMed ID: 38427192
[TBL] [Abstract][Full Text] [Related]
3. Detection and application of neurochemical profile by multiple regional
Guan J; Rong Y; Wen Y; Wu H; Qin H; Zhang Q; Chen W
Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of magnetic resonance spectroscopy in mesial temporal sclerosis: a systematic review.
Fernández-Vega N; Ramos-Rodriguez JR; Alfaro F; Barbancho MÁ; García-Casares N
Neuroradiology; 2021 Sep; 63(9):1395-1405. PubMed ID: 33851253
[TBL] [Abstract][Full Text] [Related]
5. Integrated imaging of [
Ratai EM; Alshikho MJ; Zürcher NR; Loggia ML; Cebulla CL; Cernasov P; Reynolds B; Fish J; Seth R; Babu S; Paganoni S; Hooker JM; Atassi N
Neuroimage Clin; 2018; 20():357-364. PubMed ID: 30112276
[TBL] [Abstract][Full Text] [Related]
6. Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Guevara CA; Blain CR; Stahl D; Lythgoe DJ; Leigh PN; Barker GJ
Eur J Neurol; 2010 Sep; 17(9):1193-1202. PubMed ID: 20402762
[TBL] [Abstract][Full Text] [Related]
7. Correlation between hippocampal volumes and proton magnetic resonance spectroscopy of the posterior cingulate gyrus and hippocampi in Alzheimer's disease.
Park EJ; Lyra KP; Lee HW; Caramelli P; Otaduy MCG; Leite CC
Dement Neuropsychol; 2010; 4(2):109-113. PubMed ID: 29213672
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes.
Zanigni S; Testa C; Calandra-Buonaura G; Sambati L; Guarino M; Gabellini A; Evangelisti S; Cortelli P; Lodi R; Tonon C
Parkinsonism Relat Disord; 2015 Aug; 21(8):929-37. PubMed ID: 26077167
[TBL] [Abstract][Full Text] [Related]
10. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
11. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy.
Lazeyras F; Charles HC; Tupler LA; Erickson R; Boyko OB; Krishnan KR
Psychiatry Res; 1998 May; 82(2):95-106. PubMed ID: 9754452
[TBL] [Abstract][Full Text] [Related]
12. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
13. Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy.
Lirng JF; Wang PS; Chen HC; Soong BW; Guo WY; Wu HM; Chang CY
PLoS One; 2012; 7(10):e47925. PubMed ID: 23118909
[TBL] [Abstract][Full Text] [Related]
14. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT
J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
Federico F; Simone IL; Lucivero V; Iliceto G; De Mari M; Giannini P; Mezzapesa DM; Tarantino A; Lamberti P
Mov Disord; 1997 Nov; 12(6):903-9. PubMed ID: 9399213
[TBL] [Abstract][Full Text] [Related]
17. Functional brain imaging: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(22):1-79. PubMed ID: 23074493
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease.
Firbank MJ; Harrison RM; O'Brien JT
Dement Geriatr Cogn Disord; 2002; 14(2):64-76. PubMed ID: 12145453
[TBL] [Abstract][Full Text] [Related]
19. The merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type.
Chen HC; Lirng JF; Soong BW; Guo WY; Wu HM; Chen CC; Chang CY
Cerebellum Ataxias; 2014; 1():17. PubMed ID: 26331041
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
Federico F; Simone IL; Lucivero V; Mezzapesa DM; de Mari M; Lamberti P; Petruzzellis M; Ferrari E
Ital J Neurol Sci; 1999 Aug; 20(4):223-9. PubMed ID: 10551908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
